Suppression of nicotinamide phosphoribosyltransferase expression by miR-154 reduces the viability of breast cancer cells and increases their susceptibility to doxorubicin

Suppression of nicotinamide phosphoribosyltransferase expression by miR-154 reduces the viability of breast cancer cells and increases their susceptibility to doxorubicin

Abstract Background Nicotinamide phosphoribosyltransferase (NAMPT) enzyme acts as the major enzyme in the nicotinamide adenine dinucleotide (NAD) synthesis salvage pathway. Deregulation of NAD could be associated with progression of several cancers such as breast cancer. Here, the consequence of NAM...

Full description

Bibliographic Details
Main Authors: Zahra Bolandghamat Pour, Mitra Nourbakhsh, Kazem Mousavizadeh, Zahra Madjd, Seyedeh Sara Ghorbanhosseini, Zohreh Abdolvahabi, Zahra Hesari, Samira Ezzati Mobasser
Format: Article
Language:English
Published: BMC 2019-11-01
Series:BMC Cancer
Subjects:
Nicotinamide phosphoribosyltransferase
Breast cancer
miR-154
Doxorubicin
microRNA
Online Access:http://link.springer.com/article/10.1186/s12885-019-6221-0

Internet

http://link.springer.com/article/10.1186/s12885-019-6221-0

Similar Items